5 x 10^6 UC-MSC + CM for retinitis pigmentosa

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Jun 2023: Trial registered, NCT05909488

The trials

NCT05909488: Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II

State
Not started
Phase
Phase 2 and Phase 3
People
30 planned
Started
May 2026
Primary completion
Jul 2027
Arms
EYESTEM 001-XF
Results
None posted
  1. 18 Jun 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.